Air Polishers With Erythritol in the Treatment of Dental Black Stain of Bacterial Origin
Condition(s) studied
Investigational drug(s) / intervention(s)
Erythritol air polisher: Dental prophylaxis with erythritol air polisher in patients with dental black stain
Dental prophylaxis with ultrasonic treatment: Dental prophylaxis with ultrasonic treatment in patients with dental black stain
Study summary
Black stains on the teeth, caused by the accumulation of chromogenic microorganisms that produce iron compounds, are more common in the pediatric population and have a negative impact on dental aesthetics and patients' self-esteem. The etiology of these stains remains unclear and is not related to oral hygiene. Currently, there is no definitive treatment that prevents the reappearance of these stains, and they can only be removed by mechanical removal, which can cause injuries to the tooth structure. This study aims to evaluate the effectiveness of erythritol powder air polishers, which have antimicrobial properties, compared to conventional prophylaxis in preventing the recurrence of stains.
A randomized clinical trial will be carried out with a follow-up of 12 months, during which patient satisfaction and duration of treatment will be assessed. The results of this study could provide valuable information to improve treatment and management strategies for dental stains in the affected population, thus contributing to the emotional well-being of patients and reducing damage to their tooth enamel.
Eligibility
Primary outcome measure(s)
- Recurrence of dental black stain — 3, 6, 9 and 12 months
Following dental prophylaxis (in each of the arms) the dentist will assess the recurrence of black stains at 3, 6, 9 and 12 months
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Universidad CEU Cardenal Herrera | Alfara del Patriarca | Valencia | Recruiting |
More Cardenal Herrera University trials in Spain
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06720168 on ClinicalTrials.gov ↗ ← All trials in Spain